For instance, levodopa (l-Dopa) often is combined with a DA receptor agonist, a monoamine oxidase-B (MAO-B) inhibitor, or a catechol-O-methyltransferase inhibitor to allay motor symptoms in advanced PD. This evidence concerns the gene MAOB and Parkinson disease.